Martha Serrano
Psychiatric/Mental Health · Phoenix, AZNPI 1376250951
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Brainsway USA Inc accounts for 72.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $6,537 and has fallen 84.7% since, to $1,000 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $92.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Brainsway USA Inc$6K
- Johnson & Johnson$603
- AbbVie$550
- Vanda Pharmaceuticals Inc.$537
- Otsuka America Pharmaceutical, Inc.$427
- Paratek Pharmaceuticals, Inc.$125
- plus $86 from 2 others
What the payments were for
- Consulting fees$3,00036%
- Speaking & faculty fees$3,00036%
- Food & beverage$2,26027%
- Education$681%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Brainsway USA Inc | 2 | $6,000 |
| Johnson & Johnson | 10 | $603 |
| AbbVie | 57 | $550 |
| Vanda Pharmaceuticals Inc. | 12 | $537 |
| Otsuka America Pharmaceutical, Inc. | 5 | $427 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $65 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Brainsway Deep TMS$3,000
- SPRAVATO$415
- Fanapt$380
- ABILIFY ASIMTUFII$245
- ABILIFY MAINTENA$245
- VRAYLAR$240
- REXULTI$126
- NUZYRA$125
How this compares
$8,328 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 12 | $189 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Bonnie VogesPhoenix$7K
- Brandy HammondPhoenix$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.